Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
received the Shingrix active ingredient or just the diluent; received the Shingrix active ingredient or just the diluent; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: received the Shingrix active ingredient or just the diluent) and inappropriate dose of vaccine administered (Verbatim: received the Shingrix active ingredient or just the diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK Receipt Date: 12-FEB-2025 The pharmacist contacted via chat on February 12th 2025 and mentioned that they had an incident where they do not know if a patient received the Shingrix active ingredient or just the diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. Chat was suddenly interrupted before agent could ask for additional details on the case.